Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)

Name: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)
Published: 2019
License: Public Domain

GlaxoSmithKline · 2019

ClinicalTrials.gov · Datasets · License: Public Domain · 2019

Open Source ↗

neoplasms non-small-cell-lung-cancer

neoplasms, non-small cell lung cancer, inducible t-cell co-stimulator (icos), docetaxel, standard of care, immuno-oncology agents, tigit, dostarlimab, jemperli, gsk4428859a, belrestotug, eos884448

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 883736
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.